Skip to content
10-Q

Quarterly Report

VSee Health, Inc. VSEE VSEEW

0001185185-26-001883

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 14, 2026 48.6M sh
Shares Diluted Q1 2026 · Mar 31, 2026 47.9M sh
Shares Diluted Q1 2026 · Mar 31, 2025 16.31M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $50K
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $26.75K
Capex Q1 2026 · Mar 31, 2025 $11.87K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.45M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$440.49K
Long Term Debt Q1 2026 · Mar 31, 2026 $781.58K
Long Term Debt Q1 2026 · Dec 31, 2025 $593.94K
Short Term Debt Q1 2026 · Mar 31, 2026 $524.09K
Short Term Debt Q1 2026 · Dec 31, 2025 $880.18K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.35M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $5.27M
Current Liabilities Q1 2026 · Mar 31, 2026 $11.79M
Current Liabilities Q1 2026 · Dec 31, 2025 $16.24M
Total Liabilities Q1 2026 · Mar 31, 2026 $12.7M
Total Liabilities Q1 2026 · Dec 31, 2025 $16.96M
Current Assets Q1 2026 · Mar 31, 2026 $4.84M
Current Assets Q1 2026 · Dec 31, 2025 $8.37M
Total Assets Q1 2026 · Mar 31, 2026 $19.02M
Total Assets Q1 2026 · Dec 31, 2025 $22.41M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.24
Eps Basic Q1 2026 · Mar 31, 2026 −$0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.24
Sga Expense Q1 2026 · Mar 31, 2026 $2.44M
Sga Expense Q1 2026 · Mar 31, 2025 $2.03M
Net Income Q1 2026 · Mar 31, 2026 −$2.6M
Net Income Q1 2026 · Mar 31, 2025 −$3.96M
Operating Income Q1 2026 · Mar 31, 2026 −$2.97M
Operating Income Q1 2026 · Mar 31, 2025 −$1.83M
Gross Profit Q1 2026 · Mar 31, 2026 $1.2M
Gross Profit Q1 2026 · Mar 31, 2025 $1.86M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.96M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.46M
Revenue Q1 2026 · Mar 31, 2026 $3.16M
Revenue Q1 2026 · Mar 31, 2025 $3.32M